article thumbnail

The Massachusetts Avenue of health reform

The Health Policy Exchange

At that point, he had not yet committed to the individual health insurance mandate that made his reforms possible but later became a political liability during his Presidential campaigns. in 2006 to 1.9% It was one thing to ask drivers to buy car insurance. Owning a car is a choice. in 2010, as the national average rose from 15.2%

Insurance 130
article thumbnail

How to Run DMC? It’s Tricky – FDA’s New Draft Guidance Provides Updated Recommendations on How to Best Use Data Monitoring Committees in Clinical Trials

FDA Law Blog

Clissold — The trio of CDER, CBER, and CDRH released a new draft guidance titled “ Use of Data Monitoring Committees in Clinical Trials ” that revises the 2006 guidance “Establishment and Operation of Clinical Trial Data Monitoring Committees” and, when final, will replace the 2006 guidance.

Clinic 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How hospitals can cut admission delays by 30%

Today's Hospitalist

That checklist includes patient demographics and the individual patient’s clinical needs. Key takeaways: Admission delays from the ED can adversely affect mortality, length of stay, medical errors and quality of care. One VA center reduced its admission delay by almost one-third with a series of three interventions. reduction.

article thumbnail

A Question 30 Years in the Making: Would a Final LDT Rule Withstand Judicial Scrutiny?

FDA Law Blog

The PR first sets out to establish that it has authority to regulate in vitro diagnostic “test systems” as devices, and not just the system’s individual components, such as reagents, instruments, specimen collection devices, and software. Premarket Approval or De Novo pathways). This comparison is misplaced.

article thumbnail

Draft LASIK Guidance: Why Did FDA Issue New Labeling Recommendations for Products that Already Have PMA Approved Labeling?

FDA Law Blog

Shapiro — Last summer, FDA published a draft guidance, Laser-Assisted In Situ Keratomileusis (LASIK) Lasers – Patient Labeling Recommendations (July 29, 2022) setting forth a proposal for new recommended patient‑directed labeling. It is focused on excimer lasers with premarket application (PMA) approval for LASIK in product code LZS.

article thumbnail

What every physician should know about care experience (and why it matters)

Permanente Medicine

I joined SCPMG straight from residency in 2006. I think sometimes we don’t necessarily realize the importance in the role that each of us individually as physicians can have with patients both within the exam room but also globally. And don’t forget to subscribe so you don’t miss future Permanente Medicine programming.

IT 52
article thumbnail

How to manage GLP-1s in the hospital

Today's Hospitalist

Instead, the statement supported a more individualized approach with a scheduled endoscopy if patients have no symptoms such as nausea, vomiting, dyspepsia or abdominal distention. Nor should they be. “I would not recommend starting a GLP-1 in the hospital.” However, not all outpatient endoscopy suites may be equipped to do that.